Oral Status of Patients Suffering From SCHIZophrenia Followed at Charles Perrens Hospital
Launched by CENTRE HOSPITALIER CHARLES PERRENS, BORDEAUX · Dec 6, 2019
Trial Information
Current as of June 24, 2025
Completed
Keywords
ClinConnect Summary
Schizophrenia concerns 21 million people in the world and 600 000 in France according to the World Health Organization. This pathology decreases the patient's quality of life and one patient out of two will try to commit suicide and 10% will die. Oral health is an important factor for general well being. The litterature shows that schizophrenic patients tend to visit less dental surgeries than the general population. Patients will often visit the surgery in emergency and dentist often choses to extract instead of a restorative solution. Thus, schizophrenic subjects are 3,4 more likely to be...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Schizophrenic patients and patients with schizoaffective disorders at the Charles Perrens Hospital
- • Willing to participate in the study
- • 18 years old and above
- Exclusion Criteria:
- • Patients mentally unable to participate or refusing to participate in this study.
- • Patient hospitalized under duress
- • Minor
- • Patients unable to read, speak or write French
About Centre Hospitalier Charles Perrens, Bordeaux
Centre Hospitalier Charles Perrens, located in Bordeaux, is a leading psychiatric hospital dedicated to advancing mental health care through innovative clinical research. The institution focuses on developing and evaluating new therapeutic strategies for a range of psychiatric disorders, prioritizing patient safety and ethical standards. With a collaborative approach, the Centre engages multidisciplinary teams to conduct rigorous clinical trials aimed at enhancing treatment outcomes and improving quality of life for individuals facing mental health challenges. Through its commitment to research excellence, Centre Hospitalier Charles Perrens plays a pivotal role in contributing to the evolving landscape of psychiatric care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bordeaux, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials